The US Food and Drug Administration (USFDA) approved the registration of Butuan Coconut Products Inc. (BCPI) led by Mina Montilla-Ladlad, paving the way for the local company to export virgin coconut oil (VCO) to the American market.
The USFDA registration signifies BCPI’s unwavering commitment to upholding the highest standards in quality and food safety for its VCO.
VCO, known for its potential health benefits such as improved digestion and increased energy levels, is a popular choice for health-conscious consumers.
A clinical study conducted in 2020 showed that VCO has been found effective in the rapid relief of COVID-19 symptoms and normalization of the C-reactive protein (CRP) concentration among probable and suspected cases of COVID-19 (Angeles-Agdeppa, 2024).
The study further suggests that VCO can be an effective adjunct therapy or supplement for COVID-19-positive patients showing mild-to-moderate symptoms.
Ladlad expressed gratitude to the Department of Trade and Industry (DTI) for its assistance. “Their assistance has been incredible. It’s always been DTI Agusan del Norte, DTI Caraga and the DTI Head Office who have helped us and continue to do so,” she said.
BCPI is a beneficiary of the government’s strong support system. DTI Agusan del Norte played a key role in preparing BCPI for FDA compliance through its RAPID Program, facilitating seminars and support services such as market research, market assistance and market promotion through their DTI- Coconut Farmers Industry Development Plan (CFIDP) and ensuring participation in the KMME-MME Online event during the pandemic.
DTI Caraga provided opportunities for BCPI to participate in local and Manila trade fairs, including PROPAK in Thailand, while also offering helpful seminars.
The DTI Head Office is also supporting BCPI’s preparations for EU export through their ARISE PLUS Program, a collaboration with the International Trade Centre of Switzerland and the European Union.
